Dr. Justin Pritchard's lab at Penn State focuses on studying tyrosine kinases, which are important proteins involved in many human diseases, including cancer. By combining experimental and computational techniques, the lab aims to understand how genetic variations in these proteins influence their function and responses to drugs. This research could lead to better predictions of disease risk and treatment outcomes for patients.

Dr. Sumit Chopra's research lab is focused on using artificial intelligence to improve the detection of prostate cancer through innovative MRI technology. The lab aims to make MRI diagnostics more accessible and effective, specifically for early detection of clinically significant prostate cancer (CSPCA). By leveraging machine learning to analyze reduced data from MRI scans, the team plans to enable point-of-care diagnostics that could revolutionize how prostate cancer is identified and monitored.

Dr. Kyung Hyun Sung's lab at UCLA focuses on improving the detection and diagnosis of aggressive prostate cancer, particularly among African American men who are disproportionately affected by this disease. Using advanced MRI techniques and innovative software tools, the lab aims to develop more accurate imaging models that account for racial differences in prostate cancer characteristics. The ultimate goal is to reduce disparities in prostate cancer diagnosis and treatment outcomes through enhanced imaging and analysis methods.

Dr. Yun Jiang's lab focuses on improving how we detect and characterize prostate cancer using advanced magnetic resonance imaging (MRI) techniques. The lab is developing a rapid and objective method that allows doctors to easily differentiate between clinically significant and less severe forms of prostate cancer. By innovating MRI protocols, this research aims to reduce unnecessary biopsies and improve treatment decisions for patients diagnosed with prostate cancer.

Dr. Di Zhao's lab focuses on understanding and targeting specific factors involved in advanced prostate cancer, particularly the roles of B7-H3 and ASH1L. The lab's research aims to develop new therapies that can effectively combat castration-resistant prostate cancer by targeting these molecules, which are crucial in how cancer cells interact with the immune system and the tumor microenvironment. The ultimate goal is to improve treatment outcomes for patients with aggressive prostate cancer.

Dr. Alan Pollack's lab at the University of Miami focuses on improving treatment outcomes for prostate cancer patients undergoing radiotherapy. They use advanced imaging techniques and liquid biopsies to identify early indicators of how well patients respond to treatment. This research aims to better tailor therapy for patients by integrating imaging data and circulating tumor cells into risk assessment models for more effective decision-making in cancer care.

Dr. Mirabela Rusu's lab at Stanford University focuses on using advanced imaging techniques to improve the diagnosis of prostate cancer. By developing deep learning models that analyze MRI scans, the lab aims to distinguish between aggressive and indolent forms of prostate cancer, which is crucial for preventing unnecessary biopsies and improving patient care. Their innovative approach combines pathology data with imaging to enhance the accuracy of cancer detection.

Dr. Leonardo Kayat Bittencourt's lab focuses on improving the detection of prostate cancer through advanced imaging techniques. Their key project involves developing a new MRI method called Magnetic Resonance Fingerprinting, which aims to provide faster and more accurate imaging of the prostate. This technology is designed to help avoid unnecessary biopsies for patients who are not at high risk of prostate cancer, ultimately improving patient care and reducing healthcare costs.

Dr. Joan E. Sanders' lab at the University of Washington focuses on improving the quality of life for people with transtibial amputations through advanced prosthetic technology. The main project aims to develop an automatically-adjusting prosthetic socket that adapts to changes in limb volume, relieving users of the burden of manual adjustments. By integrating smart algorithms and user-friendly interfaces, the research seeks to foster greater independence and better limb health for users.

Dr. Lei Ren's lab at the University of Maryland Baltimore focuses on improving proton radiotherapy and motion management in liver cancer treatments through innovative imaging technologies. One major project involves developing a 3D imaging system to enhance the accuracy of dose verification in proton therapy, ensuring that cancer patients receive precise treatment while minimizing harm to healthy tissue. Another key initiative is the creation of a digital phantom tool to simulate patient movements for more effective motion management during liver cancer radiotherapy, promising to increase treatment reliability.

Dr. You Zhang's lab focuses on advancing proton therapy for liver cancer treatment by enhancing motion management techniques. The team is developing a unique real-time imaging and proton plan adaptation system to improve the accuracy of dose delivery, which is crucial due to the challenges posed by liver motion during treatment. Their innovative approach integrates artificial intelligence and advanced imaging to ensure safer and more effective cancer radiotherapy.

Dr. Sunil V Rao's lab focuses on improving treatments for patients with submassive pulmonary embolism (PE) using advanced techniques like catheter-directed therapy (CDT). The research aims to assess the effectiveness and safety of CDT compared to traditional anticoagulant therapy. By investigating the long-term impacts of these treatments on patients' health and quality of life, the lab strives to change clinical practices and enhance patient outcomes.

Ulas Bagci's lab focuses on harnessing advanced deep learning techniques to predict the risk of pulmonary fibrosis in patients who have recovered from COVID-19. This research aims to identify early indicators that could lead to better therapeutic interventions and a deeper understanding of lung health post-infection. The lab combines imaging data, such as CT scans, with electronic health records to create comprehensive predictive models that address a pressing public health need.

Dr. Richard D. Rabbitt's lab focuses on studying benign paroxysmal positional vertigo (BPPV), a common cause of dizziness caused by dislodged particles in the inner ear. The research includes creating advanced models to simulate how these particles affect balance and exploring new methods to improve diagnosis and treatment for patients with this condition. By combining computational modeling with experimental techniques, the lab aims to better understand the mechanics of the inner ear and develop more effective clinical approaches.

Dr. Ravi Radhakrishnan's lab at the University of Pennsylvania investigates how cancer cells communicate with their environment to promote the spread of tumors, especially in aggressive types like triple-negative breast cancer. The research focuses on small vesicles called exosomes that cancer cells use to suppress the immune system and help tumors grow and spread in the body. By studying the physical properties of the tumor environment, such as stiffness, the lab aims to uncover new ways to combat cancer progression and enhance the effectiveness of cancer immunotherapies.

Dr. Chang-Lung Lee's lab at Duke University focuses on understanding how radiation therapy affects tissues, particularly in the context of head and neck cancer. One of their main projects aims to reduce the harmful side effects of radiation on oral tissue, specifically oral mucositis, by exploring the protective role of the p53 protein. The lab also investigates potential biomarkers for heart disease that could emerge following radiation exposure, which is crucial for identifying at-risk individuals after nuclear incidents.

Dr. Sandra Demaria's lab focuses on understanding how radiation therapy can enhance the immune response against tumors, particularly in the context of cancer immunotherapy. They are investigating how certain immune cells, called dendritic cells, are influenced by radiation and can help improve the effectiveness of treatments that unleash the immune system against cancer. The team aims to unravel the complex interactions between radiation, immune cells, and tumors to find new ways to boost patient responses to therapy.

Dr. Gayle E. Woloschak's research lab focuses on understanding the effects of internal exposure to radionuclides, which can occur due to accidents or medical treatments. They study how these radionuclides distribute within different organs at various scales, from cellular to tissue levels, to improve protective measures for health and safety. The lab combines various scientific disciplines such as radiation physics, chemistry, and biology to develop better models and countermeasures against the harmful effects of radiation exposure.

Dr. Chandan Guha's lab studies how sex differences impact the body's response to radiation exposure, aiming to improve treatments for radiation injuries. They focus on how hormones and genetic factors differ between males and females and how these differences can affect health outcomes after radiation exposure. One of their key projects is developing a new drug that could help protect the intestines from radiation damage.

Dr. Heather A. Himburg's lab focuses on understanding how biological sex influences the body's response to radiation, specifically in gastrointestinal damage. Their research primarily investigates the role of ACE2, an enzyme that may protect against radiation injury, and how its activity differs between male and female subjects. By exploring these sex-based differences, the lab aims to develop improved medical countermeasures for radiation exposure.